摘要
植入前遗传学诊断(PGD)自1990年第一次应用于患有肾上腺脑白质不足和神经发育迟滞伴性遗传的两对夫妇之后,逐步得到推广。然而其伴随的争议也不绝于耳。目前对于PGD的医学应用已得到世界各国广泛认可,而对于其非医学应用是否可被社会所接受还存在广泛的伦理学争议。针对PGD技术的不同接受程度及其引起的部分热点伦理问题进行归纳总结,希望为考虑进行PGD的患者及临床医生提供参考。
Preimplantation genetic diagnosis （PGD） was firstly applied in 1990 in two couples diagnosed as adrenoleukodystrophy and X-linked mental retardation. It is widely used now in ART. However, There is continuous controversy about PGD. The medical application of PGD is widely acceptable,but its application for the non-medical purposes is still immersed in ethical controversy. In this paper,we reviewed the different acceptability and ethical issues of PGD which provide references for both patients and doctors.
出处
《国际生殖健康／计划生育杂志》
CAS
2012年第5期354-358,共5页
Journal of International Reproductive Health/Family Planning
